Susan D. DeVore's most recent trade in Elevance Health Inc was a trade of 601 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elevance Health Inc | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 601 | 2,302 (0%) | 0% | 0 | Common Stock | |
Solventum Corp | Susan Dodson DeVore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 0 | - | - | Restricted Stock Units | |
Solventum Corp | Susan Dodson DeVore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 3,564 | - | 0 | Common Stock | |
Solventum Corp | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 3,403 | 3,403 | - | - | Restricted Stock Units | |
Unum Group | Susan Dodson DeVore | Director | Sale of securities on an exchange or to another person at price $ 80.62 per share. | 03 Mar 2025 | 5,577 | 31,819 (0%) | 0% | 80.6 | 449,610 | Common Stock |
Unum Group | Susan Dodson DeVore | Director | Sale of securities on an exchange or to another person at price $ 81.21 per share. | 03 Mar 2025 | 4,423 | 27,396 (0%) | 0% | 81.2 | 359,178 | Common Stock |
Unum Group | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 3,342 | 37,396 (0%) | 0% | 0 | Common Stock | |
Elevance Health Inc | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 1,701 (0%) | 0% | 0 | Common Stock | |
Solventum Corp | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 3,564 | 3,564 | - | - | Restricted Stock Units | |
Solventum Corp | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,980 | 5,544 | - | - | Restricted Stock Units | |
Unum Group | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 3,839 | 34,054 (0%) | 0% | 0 | Common Stock | |
Elevance Health Inc | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 1,313 (0%) | 0% | 0 | Common Stock | |
Unum Group | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,448 | 30,216 (0%) | 0% | 0 | Common Stock | |
Elevance Health Inc | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 856 (0%) | 0% | 0 | Common Stock | |
Elevance Health Inc | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 416 | 416 (0%) | 0% | 0 | Common Stock | |
Unum Group | Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 5,170 | 25,543 (0%) | 0% | 0 | Common Stock | |
Premier Inc - Ordinary Sha... | Susan D. DeVore | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2020 | 71,748 | 590,001 (0%) | 0% | 0 | Class A Common Stock | |
Premier Inc - Ordinary Sha... | Susan D. DeVore | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.70 per share. | 24 Aug 2020 | 7,945 | 518,253 (0%) | 0% | 33.7 | 267,747 | Class A Common Stock |
Unum Group | Susan D. DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 10,050 | 19,860 (0%) | 0% | 0 | Common Stock |